SAGENT/NOVAPLUS
Indication
Nosocomial pneumonia due to methicillin-sensitive Staphylococcus aureus
Nosocomial pneumonia due to methicillin-sensitive *Staphylococcus aureus* is an acute lower respiratory tract infection acquired 48 hours or more following hospital admission, specifically caused by strains of *Staphylococcus aureus* susceptible to beta-lactamase–resistant penicillins. Read more about Nosocomial pneumonia due to methicillin-sensitive Staphylococcus aureus
50 drugs 46 manufacturers
Drugs that treat it
Common Nosocomial pneumonia due to methicillin-sensitive Staphylococcus aureus therapies.
CLARIS LIFESCIE
LEVOFLOXACIN
PLAGUE·+53
AKORN INC.
LEVOFLOXACIN
PLAGUE·+53
HI-TECH/AKORN
LEVOFLOXACIN
QUINOLONES·PLAGUE·+53
GEN-SOURCE RX
LEVOFLOXACIN
PLAGUE·+53
CIPLA USA, INC.
LEVOFLOXACIN-D5W (levofloxacin/dextrose 5 % in water)
QUINOLONES·PLAGUE·+53
APP/FRESENIUS K
LEVOFLOXACIN-D5W (levofloxacin/dextrose 5 % in water)
QUINOLONES·PLAGUE·+53
WG CRITICAL CAR
LEVOFLOXACIN
QUINOLONES·PLAGUE·+53
CAMBER PHARMACE
Filter & compare in the drug finder →Opens the drug finder with Nosocomial pneumonia due to methicillin-sensitive Staphylococcus aureus preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonNosocomial pneumonia due to methicillin-sensitive *Staphylococcus aureus* is an acute lower respiratory tract infection acquired 48 hours or more following hospital admission, specifically caused by strains of *Staphylococcus aureus* susceptible to beta-lactamase–resistant penicillins.
This condition primarily affects hospitalized individuals, including intensive care unit patients and those requiring endotracheal intubation or mechanical ventilation.
Pathophysiologically, it typically develops when colonizing or aspirated bacteria invade the lower airways and alveolar spaces, triggering severe pulmonary parenchymal inflammation.
Clinically, it presents with fever, purulent sputum production, hypoxemia, leukocytosis, and new or progressive pulmonary infiltrates on chest imaging, carrying a potential risk for rapid progression to cavitary necrosis, pleural empyema, and sepsis.
- nih.gov
Nosocomial pneumonia due to methicillin-sensitive *Staphylococcus aureus* is an acute lower respiratory tract infection acquired 48 hours or more following hospital admission, specifically caused by strains of *Staphylococcus aureus* susceptible to beta-lactamase–resistant penicillins This condition primarily affects hospitalized individuals, including intensive care unit patients and those requiring endotracheal intubation or mechanical ventilation Clinically, it presents with fever, purulent s...
- nih.gov
Nosocomial pneumonia due to methicillin-sensitive *Staphylococcus aureus* is an acute lower respiratory tract infection acquired 48 hours or more following hospital admission, specifically caused by strains of *Staphylococcus aureus* susceptible to beta-lactamase–resistant penicillins
- nih.gov
Pathophysiologically, it typically develops when colonizing or aspirated bacteria invade the lower airways and alveolar spaces, triggering severe pulmonary parenchymal inflammation
Personalize your experience
Follow Nosocomial pneumonia due to methicillin-sensitive Staphylococcus aureus and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.